Updated:
ShangBay Capital
ShangBay Capital is a leading venture capital firm based in the heart of innovation. It brings investors access to best-in-class investments within the medical...
ShangBay Capital
ShangBay Capital is a leading venture capital firm based in the heart of innovation. It brings investors access to best-in-class investments within the medical device, biotechnology, and healthcare technology sectors through venture equity participation. Its investments cover founders who have built disruptive companies that address high, unmet clinical needs with novel ideas.
General information
Firm type
Venture Capital
Year founded
2015
Location
Region
North America
Country
United States
City
Palo Alto
Corporate office
789 University Ave, Palo Alto, CA 94301, United States
Principals
William Dai
Founding Managing Partner
Chaucer Shen
Managing Partner
Erik T. Engleson
Venture Partner
Rich Trimble
Senior Associate
Ethan Kau
Analyst
Andrew Chen
Senior Associate
Yajun Xu, Ph.D.
Senior Advisor
Andy Weimin Dai
Senior Advisor
Michael Wallace
Senior Technology Advisor
Mel Dong
Senior Advisor
Dr. Malcolm G. Munro
Senior Medical Advisor
Sector focus
Frequently asked questions
Does ShangBay Capital participate in fund commitments or only direct deals?
ShangBay's strategy description centers on direct venture equity participation in early-stage companies, from seed to growth. There is no public indication that it makes fund commitments, invests as a limited partner in other venture funds, or operates a fund-of-funds program.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: